Menopausal Symptom Management in Patients After Risk-Reducing Oophorectomy
Andrew M Kaunitz1, Chanda Reese, JoAnn V Pinkerton
1Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL; and Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA.
None:
(Abstracted from Obstet Gynecol 2025;146(2):223-232) Awareness of hereditary gynecologic cancer has been growing over the last few decades, and testing and prevention methods have been decreasing in cost. This means that more people who have gene mutations for these hereditary cancers more often face decisions about risk-reducing bilateral salpingo-oophorectomy (BSO).
More Related Videos
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
08:46Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Related Concept Videos
Menopause
Disorders of the Female Reproductive System
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Oogenesis
Mitral Valve Prolapse III: Nursing Management
